Showing results (21-30 of 92) with videos related to
Sort By:
Pageof 10
Neurobiology of Disease|April 12, 2019
Cardiorespiratory profiling reveals primary breathing dysfunction in Kcna1-null mice: Implications for sudden unexpected death in epilepsyHemangini Dhaibar, Nicole M Gautier, Oleg Y Chernyshev, et al.International Journal of Cardiology|August 8, 2006
Obesity is associated with higher mortality in patients with cardiogenic shockPaari Dominic Swaminathan, Monica Stancu, Prasannakumar Venkatesh, et al.Journal of Cardiovascular Electrophysiology|March 5, 2023
Effect of sacubitril-valsartan on the incidence of atrial fibrillation: A meta-analysisZoya Mohammad, Javaria Ahmad, Ali Sultan, et al.JACC. Clinical Electrophysiology|May 17, 2018
Cardiac Resynchronization Therapy May Be Antiarrhythmic Particularly in Responders: A Systematic Review and Meta-AnalysisAditya Saini, Munish Kannabhiran, Pratap Reddy, et al.Cardiology Research and Practice|January 21, 2016
Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased MortalitySurbhi Chamaria, Anand M Desai, Pratap C Reddy, et al.JACC. Case Reports|March 7, 2025
Leadless Pacemaker Pitfalls: Navigating Implantation and Postprocedure ChallengesGhazaleh Goldar, Aaron Sifuentes, Ashraf Alzahrani, et al.Heart & Lung : the Journal of Critical Care|March 17, 2007
Normal coronary arteries in patients with systolic heart failure who have higher body mass indexPrasanna Kumar Venkatesh, Janos Molnar, Paari Dominic Swaminathan, et al.Nature Reviews. Cardiology|August 5, 2022
Sulfide regulation of cardiovascular function in health and diseaseGopi K Kolluru, Rodney E Shackelford, Xinggui Shen, et al.The American Journal of Cardiology|February 8, 2025
Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid CardiomyopathyStefano H Byer, Aravinthasamy Sivamurugan, Udhayvir S Grewal, et al.Cardiovascular Endocrinology & Metabolism|June 15, 2022
Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?Sahith Reddy Thotamgari, Udhayvir Singh Grewal, Aakash R Sheth, et al.Pageof 10